Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies
Detlev Boison, Jong M. Rho
Neuropharmacology (2019) Vol. 167, pp. 107741-107741
Open Access | Times Cited: 51

Showing 26-50 of 51 citing articles:

The ketogenic diet increases Neuregulin 1 expression via elevating histone acetylation and its anti-seizure effect requires ErbB4 kinase activity
Jin Wang, Jie Huang, Shan Yao, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Neuroprotection induced by nucleosides
Tetsade Piermartiri, Carla I. Tasca
Elsevier eBooks (2024), pp. 661-676
Closed Access | Times Cited: 1
The Inheritance of Hearing Loss and Deafness: A Historical Perspective
Alessandro Martini, Andrea Cozza, Valerio Maria Di Pasquale Fiasca
Audiology Research (2024) Vol. 14, Iss. 1, pp. 116-128
Open Access | Times Cited: 1
Deep Brain Stimulation Inhibits Epileptic Seizures via Increase of Adenosine Release and Inhibition of ENT1, CD39, and CD73 Expression
Zhonghua Xiong, Jiahui Deng, Pandeng Xie, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1
Mechanisms of Ketogenic Diet Action
Robin S. B. Williams, Detlev Boison, Susan A. Masino, et al.
Oxford University Press eBooks (2024), pp. 1652-1666
Closed Access | Times Cited: 1
Sarcosine Suppresses Epileptogenesis in Rats With Effects on Hippocampal DNA Methylation
Hai‐Ying Shen, Landen Weltha, John M. Cook, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 9
Fluorescent A2A and A3 adenosine receptor antagonists as flow cytometry probes
Kiran S. Toti, Ryan G. Campbell, Hobin Lee, et al.
Purinergic Signalling (2022) Vol. 19, Iss. 3, pp. 565-578
Open Access | Times Cited: 6
Deep brain stimulation suppresses epileptic seizures in rats via inhibition of adenosine kinase and activation of adenosine A1 receptors
Pandeng Xie, Siqi Liu, Qi Huang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 9, pp. 2597-2607
Open Access | Times Cited: 3
Bipolar mania and epilepsy pathophysiology and treatment may converge in purine metabolism: A new perspective on available evidence
Scott Daniels, Detlev Boison
Neuropharmacology (2023) Vol. 241, pp. 109756-109756
Open Access | Times Cited: 3
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke
Mei‐Lin Tang, Zihao Wen, Jinghuan Wang, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 3, pp. 436-442
Open Access | Times Cited: 5
Factors associated with initiation of the modified Atkins diet in adults with drug-resistant epilepsy
Pedro J. Quiroga-Padilla, Claudia Briceño, Luis Carlos Mayor
Epilepsy & Behavior (2022) Vol. 129, pp. 108620-108620
Closed Access | Times Cited: 5
Developmental and foliation changes due to dysregulation of adenosine kinase in the cerebellum
Hoda M. Gebril, Tho Lai, Denise E. Fedele, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
The Unconventional Effects of the Ketogenic Diet (KD) in Preclinical Epilepsy
Timothy A. Simeone, Kristina A. Simeone
Epiliepsy currents/Epilepsy currents (2024) Vol. 24, Iss. 2, pp. 117-122
Open Access
Gene Therapy for Epilepsy
Kimberly Goodspeed, Dallas Armstrong, Andrea Boitnott, et al.
Oxford University Press eBooks (2024), pp. 1587-1590
Closed Access
Purinergic Signaling in Epilepsy
Tobías Engel, Nicholas Dale
Oxford University Press eBooks (2024), pp. 1526-1534
Closed Access
GLUT1 and cerebral glucose hypometabolism in human focal cortical dysplasia is associated with hypermethylation of key glucose regulatory genes
Chaitali Ghosh, Rosemary Westcott, David Skvasik, et al.
(2024)
Closed Access
Clinical Value of lncRNA MALAT1 and miR-154-5p in the Severity and Prognosis of Convulsive Status Epilepticus
Zhiwei Huang, Jie Huang, Xuanlin Zhang
Neurochemical Journal (2024) Vol. 18, Iss. 3, pp. 563-571
Closed Access
Exploring the Therapeutic Potential of the Ketogenic Diet on Neurological Disorders: A Comprehensive Review
Sai Krishna Vallamchetla
Journal of Neurology and Neuromedicine (2023) Vol. 7, Iss. 1, pp. 1-8
Open Access | Times Cited: 1
Effects of Postnatal Caffeine Exposure on Absence Epilepsy and Comorbid Depression: Results of a Study in WAG/Rij Rats
Gül İlbay, Zeynep Ikbal Dogan, Aymen Balıkçı, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 361-361
Open Access | Times Cited: 1
Monogenic Epilepsies: Channelopathies, Synaptopathies, mTorpathies, and Otheropathies
Andrea D. Praticò, Raffaele Falsaperla, Agata Polizzi, et al.
Journal of Pediatric Neurology (2021) Vol. 21, Iss. 03, pp. 146-154
Closed Access | Times Cited: 1
Specialty Grand Challenge for Brain Disease Mechanisms
Detlev Boison
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 1
An Update on the Pathways and Aspects of Epilepsy Treatment Targets
Ruksar Sande, Pravin Popatrao Kale, Angel Godad, et al.
Current Signal Transduction Therapy (2023) Vol. 18, Iss. 3
Closed Access
Adenosine A1 Receptors Participate in Excitability Changes after Cortical Epileptic Afterdischarges in Immature Rats
Pavel Mareš, Libor Uttl, Martina Laczó, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1733-1733
Open Access
Ketogenic Diet and Epigenetic Mechanisms of Epileptogenesis
Madhuvika Murugan, Fabio Tescarollo, Detlev Boison
Oxford University Press eBooks (2022), pp. 299-307
Closed Access
Recrystallization of Adenosine for Localized Drug Delivery
Ketki Y. Velankar, Mingyao Mou, Paul R. Hartmeier, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 9, pp. 3394-3404
Open Access

Scroll to top